IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer.
about
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Melatonin as a Promising Agent to Treat Ovarian Cancer: Molecular Mechanisms.Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study.Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma.Inhibiting MT2-TFE3-dependent autophagy enhances melatonin-induced apoptosis in tongue squamous cell carcinoma.Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells.Melatonin: An Anti-Tumor Agent in Hormone-Dependent CancersMelatonin Uptake by Cells: An Answer to Its Relationship with Glucose?
P2860
Q33624824-6103E999-8444-4202-94DF-395CB526F9D6Q39346336-21EFDD4F-A873-4C0D-AEFE-BB51B68CA02AQ41573017-FB560F70-D57E-4BF2-BA6A-7FC7D1ACC697Q47164243-37722D93-9019-4260-B01F-0CEE27650A24Q47578133-C707C867-B890-4F7B-8901-5F04A9E9CFACQ55065118-FAF28C3B-55AE-4519-8874-CA68B2A3E6FFQ58587207-F402A1C8-3466-4D93-B5CC-429D1F2EC5B9Q58697555-CE71323D-5EEB-48BA-B14A-EA4350891A45
P2860
IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
IGFBP3 and MAPK/ERK signaling ...... r activity in prostate cancer.
@en
type
label
IGFBP3 and MAPK/ERK signaling ...... r activity in prostate cancer.
@en
prefLabel
IGFBP3 and MAPK/ERK signaling ...... r activity in prostate cancer.
@en
P2093
P2860
P50
P356
P1476
IGFBP3 and MAPK/ERK signaling ...... or activity in prostate cancer
@en
P2093
Isabel Quiros-Gonzalez
Iván Gonzalez-Pola
Pedro Gonzalez-Menendez
Vanesa Cepas
P2860
P356
10.1111/JPI.12373
P577
2016-11-09T00:00:00Z